Citigroup’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-53,035
| Closed | -$3.17M | – | 5368 |
|
2019
Q4 | $3.17M | Sell |
53,035
-652
| -1% | -$39K | ﹤0.01% | 1375 |
|
2019
Q3 | $1.51M | Buy |
53,687
+4,862
| +10% | +$137K | ﹤0.01% | 1817 |
|
2019
Q2 | $1.85M | Buy |
48,825
+34,651
| +244% | +$1.31M | ﹤0.01% | 1698 |
|
2019
Q1 | $553K | Sell |
14,174
-94,605
| -87% | -$3.69M | ﹤0.01% | 2420 |
|
2018
Q4 | $2.32M | Buy |
108,779
+76,789
| +240% | +$1.64M | ﹤0.01% | 1443 |
|
2018
Q3 | $1.27M | Buy |
31,990
+28
| +0.1% | +$1.11K | ﹤0.01% | 1821 |
|
2018
Q2 | $1.22M | Sell |
31,962
-4,279
| -12% | -$163K | ﹤0.01% | 1742 |
|
2018
Q1 | $1.09M | Buy |
36,241
+8,977
| +33% | +$270K | ﹤0.01% | 1767 |
|
2017
Q4 | $852K | Buy |
27,264
+26,273
| +2,651% | +$821K | ﹤0.01% | 1988 |
|
2017
Q3 | $28K | Buy |
991
+889
| +872% | +$25.1K | ﹤0.01% | 3904 |
|
2017
Q2 | $2K | Sell |
102
-51
| -33% | -$1K | ﹤0.01% | 4628 |
|
2017
Q1 | $3K | Buy |
153
+149
| +3,725% | +$2.92K | ﹤0.01% | 4614 |
|
2016
Q4 | $0 | Sell |
4
-465
| -99% | – | ﹤0.01% | 5022 |
|
2016
Q3 | $8K | Buy |
+469
| New | +$8K | ﹤0.01% | 4529 |
|